THC Farmaceuticals(CBDG)
$0.020.00 (0.00%)
CBDG
THC Farmaceuticals financials statements
$0.02
At close:0.00 (0.00%)
THC Farmaceuticals (CBDG) Financial Statements
22 Followers
THC Farmaceuticals Financial Overview
THC Farmaceuticals's market cap is currently $163.18K. The company's EPS TTM is $-0.00; its P/E ratio is -15.70; THC Farmaceuticals has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Sep 23 | Sep 22 | Sep 21 | Sep 20 | Sep 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 10.00K | $ 2.23K | $ 7.58K | $ 10.19K |
| Gross Profit | $ -4.95K | $ 6.19K | $ 1.28K | $ 7.58K | $ 7.56K |
| Operating Income | $ -29.95K | $ -8.49K | $ -17.81K | $ -32.70K | $ -158.09K |
| EBITDA | $ -25.00K | $ 429.87K | $ -15.85K | $ -119.70K | $ -994.19K |
| Net Income | $ -14.98K | $ 426.90K | $ -8.42K | $ -60.45K | $ -498.57K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.71K | $ 1.71K | $ 18.84K | $ 2.59K | $ 2.55K |
| Total Assets | $ 2.75M | $ 2.78M | $ 2.80M | $ 2.33M | $ 2.53M |
| Total Debt | $ 141.52K | $ 141.52K | $ 372.66K | $ 342.72K | $ 916.72K |
| Net Debt | $ 139.80K | $ 139.80K | $ 353.82K | $ 340.14K | $ 914.17K |
| Total Liabilities | $ 142.09K | $ 142.09K | $ 587.66K | $ 551.40K | $ 1.09M |
| Stockholders' Equity | $ 3.20M | $ 3.22M | $ 2.79M | $ 2.35M | $ 1.96M |
| Cash Flow | |||||
| Free Cash Flow | $ 635.54K | $ 317.89K | $ -11.76K | $ -2.21K | $ -134.24K |
| Operating Cash Flow | $ 635.54K | $ 317.88K | $ -11.76K | $ -2.21K | $ -134.24K |
| Investing Cash Flow | $ -635.54K | $ 19.16K | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 0.00 | $ -354.17K | $ 28.01K | $ 2.24K | $ 105.07K |
Currency in USD
